{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T20:40:26Z","timestamp":1781124026966,"version":"3.54.1"},"reference-count":41,"publisher":"Elsevier BV","issue":"13","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Public Health Service","award":["AI092129"],"award-info":[{"award-number":["AI092129"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1016\/j.vaccine.2017.02.020","type":"journal-article","created":{"date-parts":[[2017,2,24]],"date-time":"2017-02-24T13:30:12Z","timestamp":1487943012000},"page":"1705-1711","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["The cationic liposomal adjuvants CAF01 and CAF09 formulated with the major outer membrane protein elicit robust protection in mice against a Chlamydia muridarum respiratory challenge"],"prefix":"10.1016","volume":"35","author":[{"given":"Sukumar","family":"Pal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delia F.","family":"Tifrea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Follmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Andersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis M.","family":"de la Maza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2017.02.020_b0005","unstructured":"Chlamydia screening among sexually active young female enrollees of health plans\u2013United States, 2000\u20132007. MMWR Morb Mortal Wkly Rep. vol. 58; 2009. p. 362\u20135."},{"key":"10.1016\/j.vaccine.2017.02.020_b0010","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1001\/jama.291.18.2229","article-title":"Prevalence of chlamydial and gonococcal infections among young adults in the United States","volume":"291","author":"Miller","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2017.02.020_b0015","series-title":"Human chlamydial infections","author":"Schachter","year":"1978"},{"key":"10.1016\/j.vaccine.2017.02.020_b0020","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/978-1-4614-4726-9_8","article-title":"Recognition and treatment of chlamydial infections from birth to adolescence","volume":"764","author":"Darville","year":"2013","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.vaccine.2017.02.020_b0025","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1080\/00365540110077001","article-title":"Is the increase in notifications of Chlamydia trachomatis infections in Sweden the result of changes in prevalence, sampling frequency or diagnostic methods?","volume":"34","author":"Gotz","year":"2002","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.vaccine.2017.02.020_b0030","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1086\/497341","article-title":"The unexpected impact of a Chlamydia trachomatis infection control program on susceptibility to reinfection","volume":"192","author":"Brunham","year":"2005","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2017.02.020_b0035","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1111\/j.1749-6632.1962.tb30558.x","article-title":"Trachoma vaccine studies on Taiwan","volume":"98","author":"Grayston","year":"1962","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.vaccine.2017.02.020_b0040","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/00007435-197804000-00011","article-title":"The potential for vaccine against infection of the genital tract with Chlamydia trachomatis","volume":"5","author":"Grayston","year":"1978","journal-title":"Sex Transm Dis"},{"key":"10.1016\/j.vaccine.2017.02.020_b0045","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/0264-410X(95)80022-6","article-title":"A new computer model for estimating the impact of vaccination protocols and its application to the study of Chlamydia trachomatis genital infections","volume":"13","author":"de la Maza","year":"1995","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.02.020_b0050","first-page":"980","article-title":"Vaccines for Chlamydia trachomatis infections","volume":"3","author":"de la Maza","year":"2002","journal-title":"Curr Opin Investig Drugs"},{"key":"10.1016\/j.vaccine.2017.02.020_b0055","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1128\/IAI.00881-10","article-title":"Vaccination against Chlamydia genital infection utilizing the murine C. muridarum model","volume":"79","author":"Farris","year":"2011","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2017.02.020_b0060","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1016\/j.vaccine.2013.10.016","article-title":"Towards a safe and effective chlamydial vaccine: lessons from the eye","volume":"32","author":"Mabey","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.02.020_b0065","doi-asserted-by":"crossref","first-page":"8153","DOI":"10.1128\/IAI.73.12.8153-8160.2005","article-title":"Vaccination with the Chlamydia trachomatis major outer membrane protein can elicit an immune response as protective as that resulting from inoculation with live bacteria","volume":"73","author":"Pal","year":"2005","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2017.02.020_b0070","doi-asserted-by":"crossref","DOI":"10.1093\/infdis\/jiv137","article-title":"Protection against Chlamydia trachomatis infection and upper genital tract pathological changes by vaccine-promoted neutralizing antibodies directed to the VD4 of the major outer membrane protein","author":"Olsen","year":"2015","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2017.02.020_b0075","doi-asserted-by":"crossref","first-page":"5201","DOI":"10.4049\/jimmunol.1303392","article-title":"Increased immunoaccessibility of MOMP epitopes in a vaccine formulated with amphipols may account for the very robust protection elicited against a vaginal challenge with Chlamydia muridarum","volume":"192","author":"Tifrea","year":"2014","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2017.02.020_b0080","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1128\/IAI.01062-12","article-title":"Toll-like receptor 2-dependent activity of native major outer membrane protein proteosomes of Chlamydia trachomatis","volume":"81","author":"Massari","year":"2013","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2017.02.020_b0085","doi-asserted-by":"crossref","first-page":"323","DOI":"10.3390\/vaccines2020323","article-title":"Immune adjuvant effect of molecularly-defined toll-like receptor ligands","volume":"2","author":"Toussi","year":"2014","journal-title":"Vaccines"},{"key":"10.1016\/j.vaccine.2017.02.020_b0090","doi-asserted-by":"crossref","first-page":"4374","DOI":"10.1128\/IAI.00622-10","article-title":"CD4+ T cells and antibody are required for optimal major outer membrane protein vaccine-induced immunity to Chlamydia muridarum genital infection","volume":"78","author":"Farris","year":"2010","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2017.02.020_b0095","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.vaccine.2013.11.100","article-title":"Characterization of protective immune responses promoted by human antigen targets in a urogenital Chlamydia trachomatis mouse model","volume":"32","author":"Olsen","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.02.020_b0100","doi-asserted-by":"crossref","first-page":"e3116","DOI":"10.1371\/journal.pone.0003116","article-title":"Cationic liposomes formulated with synthetic mycobacterial cordfactor (CAF01): a versatile adjuvant for vaccines with different immunological requirements","volume":"3","author":"Agger","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2017.02.020_b0105","doi-asserted-by":"crossref","first-page":"e6950","DOI":"10.1371\/journal.pone.0006950","article-title":"A novel liposome-based adjuvant CAF01 for induction of CD8(+) cytotoxic T-lymphocytes (CTL) to HIV-1 minimal CTL peptides in HLA-A\u22170201 transgenic mice","volume":"4","author":"Gram","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2017.02.020_b0110","doi-asserted-by":"crossref","first-page":"3927","DOI":"10.1016\/j.vaccine.2014.05.050","article-title":"Induction of CD8+ T-cell responses against subunit antigens by the novel cationic liposomal CAF09 adjuvant","volume":"32","author":"Korsholm","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.02.020_b0115","doi-asserted-by":"crossref","first-page":"8047","DOI":"10.4049\/jimmunol.0801592","article-title":"Tuberculosis subunit vaccination provides long-term protective immunity characterized by multifunctional CD4 memory T cells","volume":"182","author":"Lindenstrom","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2017.02.020_b0120","doi-asserted-by":"crossref","first-page":"e628","DOI":"10.3389\/fimmu.2015.00628","article-title":"Intramuscular priming and intranasal boosting induce strong genital immunity through secretory IgA in minipigs infected with Chlamydia trachomatis","volume":"6","author":"Lorenzen","year":"2015","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2017.02.020_b0125","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1038\/mi.2016.28","article-title":"Vaccine-induced Th17 cells are established as resident memory cells in the lung and promote local IgA responses","volume":"10","author":"Christensen","year":"2017","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.vaccine.2017.02.020_b0130","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.4049\/jimmunol.0804091","article-title":"Novel generation mycobacterial adjuvant based on liposome-encapsulated monomycoloyl glycerol from Mycobacterium bovis bacillus Calmette-Guerin","volume":"183","author":"Andersen","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2017.02.020_b0135","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1084\/jem.188.5.809","article-title":"Vaccination against chlamydial genital tract infection after immunization with dendritic cells pulsed ex vivo with nonviable Chlamydiae","volume":"188","author":"Su","year":"1998","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2017.02.020_b0140","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/0264-410X(95)00017-U","article-title":"Protective efficacy of a parenterally administered MOMP-derived synthetic oligopeptide vaccine in a murine model of Chlamydia trachomatis genital tract infection: serum neutralizing IgG antibodies do not protect against chlamydial genital tract infection","volume":"13","author":"Su","year":"1995","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.02.020_b0145","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S0264-410X(98)00219-9","article-title":"Vaccination of mice with DNA plasmids coding for the Chlamydia trachomatis major outer membrane protein elicits an immune response but fails to protect against a genital challenge","volume":"17","author":"Pal","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.02.020_b0150","doi-asserted-by":"crossref","first-page":"3074","DOI":"10.1128\/IAI.68.6.3074-3078.2000","article-title":"Priming with Chlamydia trachomatis major outer membrane protein (MOMP) DNA followed by MOMP ISCOM boosting enhances protection and is associated with increased immunoglobulin A and Th1 cellular immune responses","volume":"68","author":"Dong-Ji","year":"2000","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2017.02.020_b0155","doi-asserted-by":"crossref","first-page":"6798","DOI":"10.1128\/IAI.68.12.6798-6806.2000","article-title":"Induction of protective immunity against Chlamydia trachomatis genital infection by a vaccine based on major outer membrane protein-lipophilic immune response-stimulating complexes","volume":"68","author":"Igietseme","year":"2000","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2017.02.020_b0160","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1084\/jem.167.3.817","article-title":"High-resolution mapping of serovar-specific and common antigenic determinants of the major outer membrane protein of Chlamydia trachomatis","volume":"167","author":"Stephens","year":"1988","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2017.02.020_b0165","doi-asserted-by":"crossref","first-page":"4000","DOI":"10.1073\/pnas.85.11.4000","article-title":"Mapping antigenic domains expressed by Chlamydia trachomatis major outer membrane protein genes","volume":"85","author":"Baehr","year":"1988","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2017.02.020_b0170","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1084\/jem.172.1.203","article-title":"Identification and characterization of T helper cell epitopes of the major outer membrane protein of Chlamydia trachomatis","volume":"172","author":"Su","year":"1990","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2017.02.020_b0175","doi-asserted-by":"crossref","first-page":"5020","DOI":"10.1016\/j.vaccine.2009.05.008","article-title":"Protection against an intranasal challenge by vaccines formulated with native and recombinant preparations of the Chlamydia trachomatis major outer membrane protein","volume":"27","author":"Sun","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.02.020_b0180","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1086\/590670","article-title":"Liposome delivery of Chlamydia muridarum major outer membrane protein primes a Th1 response that protects against genital chlamydial infection in a mouse model","volume":"198","author":"Hansen","year":"2008","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2017.02.020_b0185","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.ijpharm.2009.10.043","article-title":"CAF01 liposomes as a mucosal vaccine adjuvant: in vitro and in vivo investigations","volume":"390","author":"Christensen","year":"2010","journal-title":"Int J Pharm"},{"key":"10.1016\/j.vaccine.2017.02.020_b0190","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1128\/IAI.06338-11","article-title":"Chlamydia muridarum T cell antigens and adjuvants that induce protective immunity in mice","volume":"80","author":"Yu","year":"2012","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2017.02.020_b0195","doi-asserted-by":"crossref","first-page":"4507","DOI":"10.4049\/jimmunol.0900237","article-title":"Cutting edge: lung mucosal Th17-mediated responses induce polymeric Ig receptor expression by the airway epithelium and elevate secretory IgA levels","volume":"182","author":"Jaffar","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2017.02.020_b0200","doi-asserted-by":"crossref","first-page":"7536","DOI":"10.4049\/jimmunol.175.11.7536","article-title":"A predominant role for antibody in acquired immunity to chlamydial genital tract reinfection","volume":"175","author":"Morrison","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2017.02.020_b0205","doi-asserted-by":"crossref","first-page":"6222","DOI":"10.1128\/JB.00552-07","article-title":"Structural and functional analyses of the major outer membrane protein of Chlamydia trachomatis","volume":"189","author":"Sun","year":"2007","journal-title":"J Bacteriol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17302141?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17302141?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,4]],"date-time":"2018-09-04T02:28:44Z","timestamp":1536028124000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X17302141"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":41,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["S0264410X17302141"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.02.020","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The cationic liposomal adjuvants CAF01 and CAF09 formulated with the major outer membrane protein elicit robust protection in mice against a Chlamydia muridarum respiratory challenge","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.02.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}